Deferoxamine on neurological and radiological implications for cerebral hemorrhage

The effect of defroxamine on neurological and radiological outcome after spontaneous intracerebral hemorrhage

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190325043107N30

Enrollment

Registered

2022-05-13

Start date

2022-05-31

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

level of consciousness. Other coma, without documented Glasgow coma scale score, or with partial score reported

Interventions

Intervention 1: Intervention group: Twenty-one patients with a diagnosis of spontaneous bleeding after random allocation will be included in this study. After being admitted to the relevant ward, defe

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Brain stroke Spontaneous cerebral hemorrhage Satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: Requires brain surgery Stroke over the last six months Hypersensitivity to deferoxamine

Design outcomes

Primary

Measure	Time frame
Level of consciousness. Timepoint: Before the intervention, one week and one month after the end of the intervention. Method of measurement: With the help of GCS criteria.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Shimia

Tabriz University of Medical Sciences

Shimia@tbzmed.ac.ir+98 41 3335 7310

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026